A transdiagnostic perspective of constructs underlying obsessive-compulsive and related disorders: An international Delphi consensus study.

Obsessive-compulsive and related disorders Research Domain Criteria cognitive control compulsivity habit

Journal

The Australian and New Zealand journal of psychiatry
ISSN: 1440-1614
Titre abrégé: Aust N Z J Psychiatry
Pays: England
ID NLM: 0111052

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 5 5 2020
medline: 13 7 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

The Research Domain Criteria seeks to bridge knowledge from neuroscience with clinical practice by promoting research into valid neurocognitive phenotypes and dimensions, irrespective of symptoms and diagnoses as currently conceptualized. While the Research Domain Criteria offers a vision of future research and practice, its 39 functional constructs need refinement to better target new phenotyping efforts. This study aimed to determine which Research Domain Criteria constructs are most relevant to understanding obsessive-compulsive and related disorders, based on a consensus between experts in the field of obsessive-compulsive and related disorders. Based on a modified Delphi method, 46 experts were recruited from Australia, Africa, Asia, Europe and the Americas. Over three rounds, experts had the opportunity to review their opinion in light of feedback from the previous round, which included how their response compared to other experts and a summary of comments given. Thirty-four experts completed round one, of whom 28 (82%) completed round two and 24 (71%) completed round three. At the final round, four constructs were endorsed by ⩾75% of experts as 'primary constructs' and therefore central to understanding obsessive-compulsive and related disorders. Of these constructs, one came from the Positive Valence System (Habit), two from the Cognitive Control System (Response Selection/Inhibition and Performance Monitoring) and the final construct was an additional item suggested by experts (Compulsivity). This study identified four Research Domain Criteria constructs that, according to experts, cut across different obsessive-compulsive and related disorders. These constructs represent key areas for future investigation, and may have potential implications for clinical practice in terms of diagnostic processes and therapeutic management of obsessive-compulsive and related disorders.

Sections du résumé

BACKGROUND
The Research Domain Criteria seeks to bridge knowledge from neuroscience with clinical practice by promoting research into valid neurocognitive phenotypes and dimensions, irrespective of symptoms and diagnoses as currently conceptualized. While the Research Domain Criteria offers a vision of future research and practice, its 39 functional constructs need refinement to better target new phenotyping efforts. This study aimed to determine which Research Domain Criteria constructs are most relevant to understanding obsessive-compulsive and related disorders, based on a consensus between experts in the field of obsessive-compulsive and related disorders.
METHODS
Based on a modified Delphi method, 46 experts were recruited from Australia, Africa, Asia, Europe and the Americas. Over three rounds, experts had the opportunity to review their opinion in light of feedback from the previous round, which included how their response compared to other experts and a summary of comments given.
RESULTS
Thirty-four experts completed round one, of whom 28 (82%) completed round two and 24 (71%) completed round three. At the final round, four constructs were endorsed by ⩾75% of experts as 'primary constructs' and therefore central to understanding obsessive-compulsive and related disorders. Of these constructs, one came from the Positive Valence System (Habit), two from the Cognitive Control System (Response Selection/Inhibition and Performance Monitoring) and the final construct was an additional item suggested by experts (Compulsivity).
CONCLUSION
This study identified four Research Domain Criteria constructs that, according to experts, cut across different obsessive-compulsive and related disorders. These constructs represent key areas for future investigation, and may have potential implications for clinical practice in terms of diagnostic processes and therapeutic management of obsessive-compulsive and related disorders.

Identifiants

pubmed: 32364439
doi: 10.1177/0004867420912327
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-731

Auteurs

Leonardo F Fontenelle (LF)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.
D'Or Institute for Research and Education, D'Or São Luiz Network, Rio de Janeiro, Brazil.
Obsessive, Compulsive, and Anxiety Spectrum Research Program, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Erin Oldenhof (E)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.

Maria Eduarda Moreira-de-Oliveira (M)

D'Or Institute for Research and Education, D'Or São Luiz Network, Rio de Janeiro, Brazil.
Obsessive, Compulsive, and Anxiety Spectrum Research Program, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Jonathan S Abramowitz (JS)

Department of Psychology and Neuroscience, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Martin M Antony (MM)

Department of Psychology, Ryerson University, Toronto, ON, Canada.

Danielle Cath (D)

RGOc and Department of Psychiatry, Rijksuniversity Groningen, UMC Groningen, Groningen, The Netherlands.
Department of Specialized Trainings, Mental Health Services Drenthe, Assen, The Netherlands.

Adrian Carter (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.

Darin Dougherty (D)

Division of Neurotherapeutics, Massachusetts General Hospital, Boston, MA, USA.
Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA.
Obsessive-Compulsive and Related Disorders Program, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Ygor A Ferrão (YA)

Department of Psychiatry, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.

Martijn Figee (M)

Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

Ben J Harrison (BJ)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Marcelo Hoexter (M)

Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Jun Soo Kwon (J)

Department of Psychiatry, College of Medicine, Seoul National University, Seoul, Korea.

Anne Küelz (A)

Department of Psychiatry and Psychotherapy, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Luísa Lazaro (L)

Department of Child and Adolescent Psychiatry and Psychology, Hospital Clinic of Barcelona, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain.

Christine Lochner (C)

SU/UCT MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa.

Donatella Marazziti (D)

Dipartimento di Medicina Clinica e Sperimentale, Section of Psychiatry, University of Pisa, Pisa, Italy.

David Mataix-Cols (D)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Dean McKay (D)

Department of Psychology, Fordham University, Bronx, NY, USA.

Euripedes C Miguel (EC)

Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Sharon Morein-Zamir (S)

School of Psychology and Sports Science, Anglia Ruskin University, Cambridge, UK.

Steffen Moritz (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Gerald Nestadt (G)

Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Kieron O'Connor (K)

Research Center of the Montreal University Institute of Mental Health, University of Montreal, Montreal, QC, Canada.

Stefano Pallanti (S)

Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA.
Institute of Neuroscience, University of Florence, Florence, Italy.

Christine Purdon (C)

Department of Psychology, University of Waterloo, Waterloo, ON, Canada.

Scott Rauch (S)

Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Peggy Richter (P)

Anxiety Disorders Centre, Sunnybrook Health Care Sciences, Toronto, Canada and Department of Psychiatry, University of Toronto, Toronto, Canada.

Jean-Yves Rotge (JY)

Inserm U 1127, CNRS UMR 7225, Department of Psychiatry, Institut du Cerveau et de la Moelle, ICM-A-IHU, Sorbonne Université, AP-HP, Paris, France.

Roseli G Shavitt (RG)

Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Carles Soriano-Mas (C)

Department of Psychiatry and Department of Psychobiology and Methodology of Health Sciences, Bellvitge Biomedical Research Institute-IDIBELL, Mental Health Networking Biomedical Research Centre (CIBERSAM) and Universitat Autònoma de Barcelona, Barcelona, Spain.

Vladan Starcevic (V)

Department of Psychiatry, Nepean Hospital, Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, The University of Sydney, Sydney, NSW, Australia.

Dan J Stein (DJ)

Department of Psychiatry and MRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.

Gail Steketee (G)

School of Social Work, Boston University, Boston, USA.

Eric A Storch (EA)

Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TC, USA.

Steven Taylor (S)

Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada.

Odile A van den Heuvel (OA)

Department of Psychiatry and Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.

David Veale (D)

South London and Maudsley NHS Foundation Trust, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Douglas W Woods (DW)

Department of Psychological and Brain Sciences, Texas A&M University, College Station, TX, USA.
Department of Psychology, Marquette University, Milwaukee, WI, USA.

Antonio Verdejo-Garcia (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.

Murat Yücel (M)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH